养老院抗生素管理政策与抗生素使用:2013-2017
该研究为回顾性重复横断面分析,纳入2013年317,003份和2017年267,537份长期照护居民评估,来自953家和872家自由 standing 养老院。结果显示养老院抗生素管理政策强度从2013年到2017年增加(P < .01),全部居民(包括阿尔茨海默病患者)抗生素使用率下降(P < .05),其中45%的下降归因于管理项目加强;但阿尔茨海默病合并尿路感染居民中政策强度与使用下降的关联未持续存在。
要点
- 养老院抗生素管理政策强度2013至2017年增加(P < .01)。
- 全部居民及阿尔茨海默病患者抗生素使用率下降(P < .05),45%归因于管理项目加强。
- 阿尔茨海默病合并尿路感染居民中政策强度与使用下降的关联未持续。
核心结论
- 养老院抗生素管理政策强度增加与抗生素使用率下降相关,但阿尔茨海默病合并尿路感染居民中该关联未持续,需调整项目以直接应对实施障碍和该类居民尿路感染抗生素合理使用。
研究设计与样本
- 回顾性重复横断面分析,纳入2013年317,003份和2017年267,537份长期照护居民评估,分别来自953家和872家自由 standing 养老院;调查数据与Minimum Data Set及Certification and Survey Provider Enhanced Reporting数据合并。
- 纳入对象为自由 standing 养老院中未接受临终关怀的长期照护居民,参与2013年和/或2017年调查。
主要发现
- 养老院抗生素管理政策强度从2013年到2017年增加(P < .01)。
- 全部养老院居民(包括阿尔茨海默病患者)抗生素使用率下降(P < .05),45%的下降归因于管理项目加强。
- 对大多数居民,政策强度与尿路感染居民使用下降相关;但在阿尔茨海默病合并尿路感染居民中该关联未持续。
关键数值与推荐
- 结局为抗生素使用的二分类指标,主要预测因子为养老院抗生素管理政策强度,采用多变量线性回归模型调整两年间不同的居民和机构特征。
- 2013年样本317,003份居民评估、953家养老院;2017年样本267,537份居民评估、872家养老院。
临床怎么用
- 持续加强养老院抗生素管理项目,并针对实施障碍和阿尔茨海默病居民尿路感染抗生素合理使用进行调整。
- 需更多时间观察抗生素管理政策全面落地后的影响。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Reducing inappropriate nursing home (NH) antibiotic usage by implementing stewardship programs is a national priority. Our aim is to evaluate the influence of antibiotic stewardship programs on antibiotic use rates in NHs over time. DESIGN: Retrospective, repeated cross-sectional analysis. SETTING AND PARTICIPANTS: Long-term residents not receiving hospice care in freestanding NHs that participated in 1 or both surveys in 2013 and 2017. METHODS: Survey data were merged with the Minimum Data Set and the Certification and Survey Provider Enhanced Reporting data. Our outcome was a binary indicator for antibiotic use. The main predictor was the NH antibiotic stewardship policy intensity. Using multivariate linear regression models adjusting for resident and facility characteristics that differed between the 2 years, we calculated antibiotic use rates in 2013 and 2017 for all residents, those with Alzheimer's disease, and those with any infection including urinary tract infections (UTIs). RESULTS: Our sample included 317,003 resident assessments from 2013 and 267,537 assessments from 2017, residing in 953 and 872 NHs, respectively. NH antibiotic stewardship policy intensity increased from 2013 to 2017 (P < .01) and among all NH residents, including those with Alzheimer's disease, antibiotic use rate decreased (P < .05), with 45% of the decline attributable to strengthening stewardship programs. For most residents, policy intensity was associated with decreased usage in residents with UTI. However, among Alzheimer's disease residents with a UTI, this association did not persist. CONCLUSIONS AND IMPLICATIONS: Although there was a decrease in antibiotic use in 2017, more time is needed to see the full impact of antibiotic stewardship policy into practice. Adjustments to programs that directly address barriers to implementation and appropriate UTI antibiotic use for residents with Alzheimer's disease are necessary to continue strengthening NH antibiotic stewardship and improve care.
引用
- Agarwal M, Estrada LV, Gracner T, et al. Nursing Home Antibiotic Stewardship Policy and Antibiotics Use: 2013-2017. J Am Med Dir Assoc. 2021. PMID: 34297980. doi:10.1016/j.jamda.2021.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。